Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

International research team establishes leptin-brain-bone mass link

Jan. 27, 2000

Generex presents latest results for oral insulin formulation

Jan. 27, 2000

Genetic basis of preeclampsia identified by Pittsburgh researchers

Jan. 27, 2000

Metabolex acquires Shaman's antidiabetic drug development program

Jan. 26, 2000

Ontogen achieves milestone in PTPase collaboration with Novo Nordisk

Jan. 26, 2000

New growth hormone option increases patient convenience

Jan. 25, 2000

Chiron discloses inhibitors of GSK3 activity and their use

Jan. 25, 2000

Georgetown University to study Magainin's squalamine for diabetic retinopathy

Jan. 24, 2000

Genotropin delivery device now available for long-term replacement therapy in GHD

Jan. 24, 2000

Lipitor recommended for approval in Japan

Jan. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...